The Journal of Thoracic and Cardiovascular Surgery
Volume 135, Issue 4 , Pages 843-849 , April 2008

Remediastinoscopy in restaging of lung cancer after induction therapy

  • Alessandro Marra, MD

      Affiliations

    • Department of Thoracic Surgery and Endoscopy, Ruhrlandklinik, Essen, Germany
    • Corresponding Author InformationAddress for reprints: Alessandro Marra, MD, Department of Thoracic Surgery and Endoscopy, Ruhrlandklinik, Tüschener Weg 40, D-45239 Essen, Germany.
    • ,
  • Ludger Hillejan, MD

      Affiliations

    • Department of Thoracic Surgery, Klinikum St Georg, Ostercappeln, Germany
    • ,
  • Sylvia Fechner, MD

      Affiliations

    • Department of Thoracic Surgery and Endoscopy, Ruhrlandklinik, Essen, Germany
    • ,
  • Georgios Stamatis, MD

      Affiliations

    • Department of Thoracic Surgery and Endoscopy, Ruhrlandklinik, Essen, Germany

Received 10 June 2007 ,Revised 10 June 2007 ,Accepted 30 July 2007.

References 

  1. Albain KS, Rusch VW, Crowley JJ, Rice TW, Turrisi AT, Weick JK, et al. Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stage IIIA (N2) and IIIB non-small-cell lung cancer. J Clin Oncol. 1995;13:1880–1892
  2. Eberhardt W, Wilke H, Stamatis G, Stuschke M, Harstrick A, Menker H, et al. Preoperative chemotherapy followed by concurrent chemoradiation therapy based on hyperfractionated accelerated radiotherapy and definitive surgery in locally advanced non-small cell lung cancer: mature results of a phase II trial. J Clin Oncol. 1998;16:622–634
  3. Eberhardt W, Stamatis G, Stuschke M, Wilke H, Muller MR, Kolks S, et al. Prognostically orientated multimodality treatment including surgery for selected patients of small-cell lung cancer patients stages IB to IIIB: long-term results of a phase II trial. Br J Cancer. 1999;81:1206–1212
  4. Bueno R, Richards W, Swanson SJ, Jaklitsch MT, Lukanich JM, Mentzer SJ, et al. Nodal stage after induction therapy for stage IIIA lung cancer determines patient survival. Ann Thorac Surg. 2000;70:1826–1831
  5. Voltolini L, Luzzi L, Ghiribelli C, Paladini P, Di Bisceglie M, Gotti G. Results of induction chemotherapy followed by surgical resection in patients with stage IIIA (N2) non-small cell lung cancer: the importance of the nodal down-staging after chemotherapy. Eur J Cardiothorac Surg. 2001;20:1106–1112
  6. Betticher DC, Hsu Schmitz SF, Totsch M, Hansen E, Joss C, von Briel C, et al. Mediastinal lymph node clearance after docetaxel-cisplatin neoadjuvant chemotherapy is prognostic of survival in patients with stage IIIA pN2 non-small-cell lung cancer: a multicenter phase II trial. J Clin Oncol. 2003;21:1752–1759
  7. Dillemans B, Deneffe G, Verschakelen J, Decramer M. Value of computed tomography and mediastinoscopy in preoperative evaluation of mediastinal nodes in non-small cell lung cancer. A study of 569 patients. Eur J Cardiothorac Surg. 1994;8:37–42
  8. Mateu-Navarro M, Rami-Porta R, Bastus-Pilatus R. Remediastinoscopy after induction chemotherapy in non-small cell lung cancer. Ann Thorac Surg. 2000;70:391–395
  9. Gould MK, Kuschner WG, Rydzak CE, Maclean CC, Demas AN, Shigemitsu H, et al. Test performance of positron emission tomography and computed tomography for mediastinal staging in patients with non-small-cell lung cancer. Ann Intern Med. 2003;139:879–892
  10. Cerfolio RJ, Bryant AS, Ojha B. Restaging patients with N2 (stage IIIa) non-small cell lung cancer after neoadjuvant chemoradiotherapy: a prospective study. J Thorac Cardiovasc Surg. 2006;131:1229–1235
  11. De Leyn P, Stroobants S, De Wever W, Lerut T, Coosemans W, Decker G, et al. Prospective comparative study of integrated positron emission tomography-computed tomography scan compared with remediastinoscopy in the assessment of residual mediastinal lymph node disease after induction chemotherapy for mediastinoscopy-proven stage IIIA-N2 Non-small-cell lung cancer: a Leuven Lung Cancer Group Study. J Clin Oncol. 2006;24:3333–3339
  12. Ukena D, Hellwig D. Value of FDG PET in the management of NSCLC. Lung Cancer. 2004;45(suppl):S75–S78
  13. Poettgen C, Levegrun S, Theegarten D, Marnitz S, Grehl S, Pink R, et al. Value of 18F-fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography in non-small-cell lung cancer for prediction of pathologic response and times to relapse after neoadjuvant chemoradiotherapy. Clin Cancer Res. 2006;12:97–106
  14. Annema JT, Veselic M, Versteegh MI, Willems LN, Rabe KF. Mediastinal restaging: EUS-FNA offers a new perspective. Lung Cancer. 2003;42:311–318
  15. Meersschaut D, Vermassen F, Brutel de la Riviere A, Knaepen PJ, Van den Bosch JM, Vanderschueren R. Repeat mediastinoscopy in the assessment of new and recurrent lung neoplasm. Ann Thorac Surg. 1992;53:120–122
  16. Olsen PS, Stentoft P, Ellefsen B, Pettersson G. Re-mediastinoscopy in the assessment of resectability of lung cancer. Eur J Cardiothorac Surg. 1997;11:661–663
  17. Pauwels M, Van Schil P, De Backer W, Van den Brande F, Eyskens E. Repeat mediastinoscopy in the staging of lung cancer. Eur J Cardiothorac Surg. 1998;14:271–273
  18. Van Schil P, van der Schoot J, Poniewierski J, Pauwels M, Carp L, Germonpre P, et al. Remediastinoscopy after neoadjuvant therapy for non-small cell lung cancer. Lung Cancer. 2002;37:281–285
  19. Rami-Porta R, Mateu-Navarro M, Serra-Mitjans M, Fernandez-Rodriguez H. Remediastinoscopy: comments and updated results. Lung Cancer. 2003;42:363–364
  20. Mountain CF, Dresler CM. Regional lymph node classification for lung cancer staging. Chest. 1997;111:1718–1723
  21. Stamatis G, Fechner S, Hillejan L, Hinterthaner M, Krbek T. Repeat mediastinoscopy as a restaging procedure. Pneumologie. 2005;59:862–866
  22. De Waele M, Hendriks J, Lauwers P, Ortmanns P, Vanroelen W, Morel AM, et al. Nodal status at repeat mediastinoscopy determines survival in non-small cell lung cancer with mediastinal nodal involvement, treated by induction therapy. Eur J Cardiothorac Surg. 2006;29:240–243
  23. Rusch VW. Mediastinoscopy: an endangered species?. J Clin Oncol. 2005;23:8283–8285
  24. Goldstraw P. Selection of patients for surgery after induction chemotherapy for N2 non–small-cell lung cancer. J Clin Oncol. 2006;24:3317–3318
  25. Van Schil P, Stamatis G. Sensitivity of remediastinoscopy: influence of adhesions, multilevel N2 involvement, or surgical technique?. J Clin Oncol. 2006;5338

PII: S0022-5223(07)01957-5

doi: 10.1016/j.jtcvs.2007.07.073

The Journal of Thoracic and Cardiovascular Surgery
Volume 135, Issue 4 , Pages 843-849 , April 2008

Article Tools

* Image Usage & Resolution